William R. Rohn

Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA.

Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland.

Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA.

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

La Jolla Institute for Allergy & Immunology is a non-profit organization located in La Jolla, CA. The private company focuses on immunology research and aims to unravel the complexities of the immune system to tackle an array of diseases such as asthma, cancer, COVID-19, type 1 diabetes, and Parkinson's. The company is home to three research centers that focus on autoimmune conditions, cancer, and infectious diseases. The company offers various services such as bioinformatics, clinical studies, cryo-em, flow cytometry, histopathology, immunometabolism, microscopy & histology, and next-generation sequencing. The company also provides licensing opportunities and initiatives. The company was founded by Steve Pontell and is currently led by Erica Saphire as the CEO.

Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for positioning, manipulation, and stable control of catheters and catheter-based technologies. It offers Sensei Robotic Catheter System which allows physicians to instinctively navigate flexible catheters with stability and control in interventional procedures within the atria heart chambers. The company was founded by Frederic H. Moll, Daniel T. Wallace, Marvin J. Slepian, and Robert G. Younge on November 18, 2002 and is headquartered in Redwood City, CA.

Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.